NCT05060328
Breast Cancer Type: HER2+, HR+ & HER2-negative, Triple Negative
Hormone Mutations: ER+, PR+
Other Mutations: 
Breast Cancer Tissue: 
Recruitment Status: Recruiting

Drug Category: Other

Key Eligibility Criteria:

Gender: All
Age: 18 Years to 80 Years (Adult, Older Adult)
Location of Metastases: 
Additional Notes: Patients must be scheduled for surgery under general anesthesia; Patients must have Spanish as their primary language and will require translation services as part of standard care
Exclusions: Patients who have chronic pain, Patients who are undergoing a craniotomy
https://ClinicalTrials.gov/show/NCT05060328